MOA amended to enable bonus share issue; authorised capital increased

Corporate Actions View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-7.0%Reaction day

₹0.43

prior close

₹0.42

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-0.2%-6.8% vs market

Other Financial Services peers, median of 78sector+0.0%-7.0% vs sector

On the reaction day the stock moved 6.8 pts less than Nifty Microcap 250 and 7.0 pts less than its Other Financial Services peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+2.4

10m

+2.4

15m

+2.4

30m

+2.4

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-7.0-0.2-6.8+0.0-7.0

Next day

-2.3-0.2-2.2-0.2-2.1

-7.0-0.5-6.5-0.1-6.8

-7.0+0.9-7.9-0.7-6.3

-9.3+0.9-10.2-1.7-7.6

-4.7+2.5-7.1-1.4-3.2

-9.3+4.0-13.3-0.0-9.3

15d

-14.0-0.4-13.6-4.4-9.5

-16.3+2.4-18.7-3.8-12.5

-25.6+7.8-33.4-7.9-17.7

-27.9+8.0-35.9-8.3-19.6

UpDownMarket · Nifty Microcap 250Sector · Other Financial Services peers, median of 78Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Biogen Pharmachem Industries received shareholder approval via postal ballot (notice dated 23 March 2026) for issuing bonus shares and increasing its authorised share capital. The company has amended the capital clause of its Memorandum of Association to reflect this change. Bonus ratio and record date are not specified in this filing.

Likely market impact

Bonus shares will expand total share count, typically lowering per-share price proportionally. No cash outflow, but no added value for shareholders either.